Armina A. Kazi

861 total citations
22 papers, 708 citations indexed

About

Armina A. Kazi is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Armina A. Kazi has authored 22 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 12 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Armina A. Kazi's work include Estrogen and related hormone effects (13 papers), Histone Deacetylase Inhibitors Research (5 papers) and Angiogenesis and VEGF in Cancer (5 papers). Armina A. Kazi is often cited by papers focused on Estrogen and related hormone effects (13 papers), Histone Deacetylase Inhibitors Research (5 papers) and Angiogenesis and VEGF in Cancer (5 papers). Armina A. Kazi collaborates with scholars based in United States. Armina A. Kazi's co-authors include Robert D. Koos, Gauri Sabnis, Preeti Shah, Angela Brodie, Olga Goloubeva, Rabia A. Gilani, Patrice M. Becker, Saranya Chumsri, Mark S. Roberson and Raj Wadgaonkar and has published in prestigious journals such as Cancer Research, Endocrinology and Annals of the New York Academy of Sciences.

In The Last Decade

Armina A. Kazi

22 papers receiving 695 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Armina A. Kazi United States 13 394 205 192 169 89 22 708
Helen N. Pemberton United Kingdom 14 723 1.8× 333 1.6× 182 0.9× 110 0.7× 73 0.8× 22 1.0k
Qi Che China 22 578 1.5× 188 0.9× 395 2.1× 92 0.5× 42 0.5× 30 948
И. В. Кондакова Russia 15 378 1.0× 129 0.6× 151 0.8× 52 0.3× 55 0.6× 108 616
Fangfang Bi China 21 560 1.4× 194 0.9× 347 1.8× 52 0.3× 162 1.8× 48 984
Xiao Xiang China 11 226 0.6× 247 1.2× 196 1.0× 234 1.4× 126 1.4× 37 626
Andrzej Wincewicz Poland 15 393 1.0× 190 0.9× 219 1.1× 49 0.3× 39 0.4× 75 749
Rehana Qureshi United States 14 453 1.1× 164 0.8× 321 1.7× 44 0.3× 55 0.6× 22 715
Chunping Qiu China 19 432 1.1× 119 0.6× 282 1.5× 34 0.2× 83 0.9× 31 741
Dwight E. Saunders United States 14 212 0.5× 163 0.8× 102 0.5× 211 1.2× 38 0.4× 18 675
Aurelia Vattai Germany 15 226 0.6× 120 0.6× 107 0.6× 70 0.4× 65 0.7× 49 641

Countries citing papers authored by Armina A. Kazi

Since Specialization
Citations

This map shows the geographic impact of Armina A. Kazi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armina A. Kazi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armina A. Kazi more than expected).

Fields of papers citing papers by Armina A. Kazi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Armina A. Kazi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armina A. Kazi. The network helps show where Armina A. Kazi may publish in the future.

Co-authorship network of co-authors of Armina A. Kazi

This figure shows the co-authorship network connecting the top 25 collaborators of Armina A. Kazi. A scholar is included among the top collaborators of Armina A. Kazi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Armina A. Kazi. Armina A. Kazi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kazi, Armina A., et al.. (2016). Abstract 1062: Overexpression of miRNAs 181a and 222 play a role in triple negative breast cancer, and are targeted by entinostat. Cancer Research. 76(14_Supplement). 1062–1062. 1 indexed citations
2.
Kazi, Armina A., et al.. (2015). Histone Deacetylase Inhibitor Entinostat Inhibits Tumor-Initiating Cells in Triple-Negative Breast Cancer Cells. Molecular Cancer Therapeutics. 14(8). 1848–1857. 79 indexed citations
3.
Sabnis, Gauri, Bambang S. Adiwijaya, Gabriela Garcia, et al.. (2015). Seribantumab, an Anti-ERBB3 Antibody, Delays the Onset of Resistance and Restores Sensitivity to Letrozole in an Estrogen Receptor–Positive Breast Cancer Model. Molecular Cancer Therapeutics. 14(11). 2642–2652. 19 indexed citations
4.
Shah, Preeti, Gauri Sabnis, Olga Goloubeva, et al.. (2015). Histone deacetylase inhibitor entinostat in combination with a retinoid downregulates HER2 and reduces the tumor initiating cell population in aromatase inhibitor-resistant breast cancer. Breast Cancer Research and Treatment. 152(3). 499–508. 10 indexed citations
5.
Kazi, Armina A., Rabia A. Gilani, Saranya Chumsri, et al.. (2014). Nonhypoxic regulation and role of hypoxia-inducible factor 1 in aromatase inhibitor resistant breast cancer. Breast Cancer Research. 16(1). R15–R15. 33 indexed citations
6.
Kazi, Armina A., et al.. (2013). Zoledronic Acid Reverses the Epithelial–Mesenchymal Transition and Inhibits Self-Renewal of Breast Cancer Cells through Inactivation of NF-κB. Molecular Cancer Therapeutics. 12(7). 1356–1366. 26 indexed citations
7.
Sabnis, Gauri, Olga Goloubeva, Armina A. Kazi, Preeti Shah, & Angela Brodie. (2013). HDAC Inhibitor Entinostat Restores Responsiveness of Letrozole-Resistant MCF-7Ca Xenografts to Aromatase Inhibitors through Modulation of Her-2. Molecular Cancer Therapeutics. 12(12). 2804–2816. 53 indexed citations
8.
Sabnis, Gauri, et al.. (2013). Effect of selumetinib on the growth of anastrozole-resistant tumors. Breast Cancer Research and Treatment. 138(3). 699–708. 11 indexed citations
9.
Kazi, Armina A., et al.. (2013). Abstract 95: Inhibiiton of non-hypoxic HIF-1 expression in letrozole-resistant breast cancer cells reduces their cancer stem cell characteristics.. Cancer Research. 73(8_Supplement). 95–95. 2 indexed citations
10.
Gilani, Rabia A., Armina A. Kazi, Preeti Shah, et al.. (2012). The importance of HER2 signaling in the tumor-initiating cell population in aromatase inhibitor-resistant breast cancer. Breast Cancer Research and Treatment. 135(3). 681–692. 31 indexed citations
11.
Sabnis, Gauri, et al.. (2012). Abstract 2919: Effect of selumetinib and AZD8055 on the growth of anastrozole resistant tumors. Cancer Research. 72(8_Supplement). 2919–2919. 2 indexed citations
12.
Kazi, Armina A., et al.. (2010). Abstract PD05-03: HDAC Inhibitor Entinostat Restores Responsiveness of Letrozole Resistant MCF-7Ca Xenografts to AIs through Modulation of Her-2. Cancer Research. 70(24_Supplement). PD05–3. 3 indexed citations
13.
14.
15.
Koos, Robert D., et al.. (2008). HIF-1's Role in Estrogen-Induced VEGF Expression in the Uterus.. Biology of Reproduction. 78(Suppl_1). 276–276. 1 indexed citations
16.
17.
18.
Koos, Robert D., et al.. (2005). New Insight into the Transcriptional Regulation of Vascular Endothelial Growth Factor Expression in the Endometrium by Estrogen and Relaxin. Annals of the New York Academy of Sciences. 1041(1). 233–247. 36 indexed citations
19.
Becker, Patrice M., Armina A. Kazi, Raj Wadgaonkar, et al.. (2003). Pulmonary Vascular Permeability and Ischemic Injury in Gelsolin-Deficient Mice. American Journal of Respiratory Cell and Molecular Biology. 28(4). 478–484. 41 indexed citations
20.
Kazi, Armina A., Won Suk Lee, Elizabeth M. Wagner, & Patrice M. Becker. (2000). VEGF, fetal liver kinase-1, and permeability increase during unilateral lung ischemia. American Journal of Physiology-Lung Cellular and Molecular Physiology. 279(3). L460–L467. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helen N. Pemberton Breakdown of academic impact, for papers by Qi Che Breakdown of academic impact, for papers by И. В. Кондакова Breakdown of academic impact, for papers by Fangfang Bi Breakdown of academic impact, for papers by Xiao Xiang Breakdown of academic impact, for papers by Andrzej Wincewicz Breakdown of academic impact, for papers by Rehana Qureshi Breakdown of academic impact, for papers by Chunping Qiu Breakdown of academic impact, for papers by Dwight E. Saunders Breakdown of academic impact, for papers by Aurelia Vattai
Rankless by CCL
2026